DLPIC
AGN

Davide Leone & Partners Investment Company’s Allergan plc AGN Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-253,050
Closed -$44.8M – 27
2020
Q1 		$44.8M Sell
253,050
-253,050
-50% -$47.6M 6.33% 6
2019
Q4 		$96.8M Buy
+506,100
New +$91.3M 12.42% 2
2017
Q1 		– Sell
-254,193
Closed -$53.4M – 15
2016
Q4 		$53.4M Sell
254,193
-29,000
-10% -$6.01M 6.4% 8
2016
Q3 		$65.2M Hold
283,193
– – 6.35% 10
2016
Q2 		$65.4M Buy
+283,193
New +$65.3M 8.33% 5

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Davide Leone & Partners Investment Company's AGN Position: Q2 2020 in Review

Davide Leone & Partners Investment Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 253,050 shares — an estimated $44.8M sold.

Davide Leone & Partners Investment Company first reported a position in AGN in Q2 2016 and held it in 5 quarters. The position peaked at $96.8M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Davide Leone & Partners Investment Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 253,050 Allergan plc shares in Q2 2020, an estimated $44.8M.
  • Davide Leone & Partners Investment Company first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • Davide Leone & Partners Investment Company's Allergan plc position peaked at $96.8M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.